Figure 3.

1H NMR spectra. Sorafenib in DMSO (a); SORA-NP, sorafenib-incorporated nanoparticles in DMSO (b); and SORA-NP in D2O (c). The box shows typical peaks of sorafenib (a), and the arrow shows typical peaks of PLGA (b).

Kim et al. Nanoscale Research Letters 2012 7:91   doi:10.1186/1556-276X-7-91
Download authors' original image